SAVA
Cassava Sciences Inc
-13.96%
$29.88 - $25.71
Feb 7th 2023 - Mar 21st 2023
Mar, 21, 2023
$CDTX FDA decision will be made tomorrow $SAVA, $M... See more
Jan, 11, 2023
$SAVA I'm loving the move, can't wait for ... See more
HTGM
HTG Molecular Diagnostics Inc
-37.26%
$4.67 - $2.93
Feb 7th 2023 - Mar 21st 2023
Jan, 13, 2023
$HTGM is over 100% since yesterday, looks for a go... See more
Dec, 27, 2022
Plus it is expecting more positive catalysts in we... See more
KALA
Kala Pharmaceuticals Inc
-9.01%
$16.65 - $15.15
Feb 7th 2023 - Mar 21st 2023
Jan, 9, 2023
$KALA is the one up 500% on Phase 2 results where ... See more
Jan, 4, 2023
$CTMX $KALA the next big runner after approval tomorrow wow! !
Mar, 21, 2023
$CDTX FDA decision will be made tomorrow $SAVA, $MDGL & $RETA boys I can easily see this up 200%-300% in my opinion on an approval.
Jan, 11, 2023
$SAVA I'm loving the move, can't wait for the approval, buy out at $500, sell at $1200.
Jan, 7, 2023
$SAVA diseases like Alzheimer’s will have more Than 1 drug approved for the indication.. being first is great,
Jan, 6, 2023
$SAVA FDA approved Biogen's AD drug is bullish for SAVA.
Jan, 6, 2023
$SAVA biib up 3.00 on approval sava will go up 100+ on approval
Jan, 6, 2023
no more speculation, now it's real, two FDA approved meds, two major products, top of the line in comparison of their rivals, for cheaper price, AND WITH NO MUCH COMPETITION!
Jan, 6, 2023
$SAVA When FDA approved Aduhelm (aducanumab), which was a failure, on June 7 2021, SAVA was up 33% within a day following that news! !
Nov, 6, 2022
This formula has already proved to be effective, and if FDA approved can potentially be sold for billions.
Oct, 20, 2022
This share price is a steal with those great Levo results this morning, and their other 3 approved and growing products.
Oct, 14, 2022
Simufilam boosts soluble level of Amyloid bera42 which in turn improves or maintains cognition in Alz patients This, along with its superior safety profile, will win the approval undoubtedly!
Jan, 13, 2023
$HTGM is over 100% since yesterday, looks for a good entry $KERN had a lot of volume yesterday $1.5 can be a good entry $VYNE announce split has been approved by board and can be executed at any time
Dec, 27, 2022
Plus it is expecting more positive catalysts in weeks and months: 5 year data for breast cancer, Canada approval, China commercialziation, and much more.
Dec, 14, 2022
FDA approved.
Jan, 9, 2023
$KALA is the one up 500% on Phase 2 results where FDA approval of any possible kind is many years away and where the company is burning through $80 million per year for zero results.
Jan, 4, 2023
$CTMX $KALA the next big runner after approval tomorrow wow! !
Dec, 28, 2022
$KALA FDA approved!
Dec, 28, 2022
Successful development and potential approval for KPI-012 will be a huge boost for the company.